Arvinder Dhalla

Program Director

Arvinder Dhalla

Arvinder joined InCube labs in March 2016 with more than 15 years of experience in pharmaceutical research & development, project management and regulatory submissions across several therapeutic areas including, cardiovascular, metabolic diseases and PAH. Previously, Arvinder was Director of Biology in the Cardiovascular Therapeutic Area at Gilead Sciences from 2009-2015 where she led multiple drug development programs from early discovery to clinical development. Arvinder led several programs as a scientist and senior scientist from 2001-2008 at CV Therapeutics which was acquired by Gilead Sciences. Arvinder holds several patents and has authored 50 scientific papers. Arvinder hold a BS and MS in Biophysics from Panjab University, India and a PhD in Physiology from University of Manitoba, Canada.